Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP)
| CAPS Rating |
|
|---|---|
| Open | $48.63 |
| Previous Close | $48.89 |
| Daily Range | $44.52 - $48.71 |
| 52-Week Range | $25.64 - $50.28 |
| Market Cap | $2.85B |
| P/E Ratio | 43.50 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 3,470,841 |
| Average Daily Volume | 0 |
SLXP
VS S&P 500 (SPY)
How do you think SLXP will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
SLXP Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
SLXP News and Commentary
- Salix Scores with Oral Relistor - Analyst Blog – NASDAQ
- Salix Pharmaceuticals Shares Popped: What You Need to Know – The Motley Fool
- US Stock Futures: HOT STOCKS TO WATCH – SmartMoney
- US Stock Futures: HOT STOCKS TO WATCH – SmartMoney
- Salix Pharmaceuticals - Aggressive Growth – NASDAQ
- Don't Get Too Worked Up Over ViroPharma's Latest Numbers – The Motley Fool
- Salix Pharmaceuticals Earnings Preview – The Motley Fool
- Let's Check Salix Pharmaceuticals' Growth – The Motley Fool
- One Reason the Street Should Expect Big Things From Salix Pharmaceuticals – The Motley Fool
- Bathwater Baby Bottoms – Blog at The Motley Fool
- The 20 Fastest Growers in Pharma – The Motley Fool
- The 9 Top Value-Creating Pharmaceutical Companies – The Motley Fool
- Is ViroPharma Going to Burn You? – The Motley Fool
- 1 Reason the Street Should Expect Big Things From ViroPharma – The Motley Fool
- Is Salix Pharmaceuticals Hiding Weakness? – The Motley Fool
- 4-Star Stocks Poised to Pop: ViroPharma – The Motley Fool
- Candy Maker Nestle Bids $1 Billion to Study Stomach Problems – Minyanville
- This Just In: More Upgrades and Downgrades – The Motley Fool
- Salix Sued by Partner for "Breach" Over HIV-Associated Drug – The Motley Fool
- Delcath's Disappointing Delay – The Motley Fool
RSS Headlines
Fool UK
